This week we look at manufacturing investments taking place in life sciences, the Food and Drug Administration’s first Safer Technologies Program approval as well as the agency’s first full approval of a COVID-19 rapid antigen test. Finally, we highlight a story on the thriving canine population of ... READ MORE >